HIMS Earnings & Financial Statements
Hims & Hers Health, Inc.
$26.94
-$0.78(-2.81%)
51
Overall
40
Value
54
Tech
60
Quality
Market Cap
$6.47B
Volume
4.90M
52W Range
$13.74 - $65.30
Target Price
$31.77
HIMS earnings and financial statements: Hims & Hers Health, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
HIMS Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $2.35B | $1.48B | $872.00M | $526.92M | $271.88M |
| Cost of revenue | $614.26M | $303.38M | $157.05M | $118.19M | $67.38M |
| Operating income | $105.61M | $61.90M | -$29.45M | -$68.70M | -$115.04M |
| EBITDA | $182.96M | $88.80M | -$12.06M | -$58.23M | -$110.97M |
| Net income | $128.37M | $126.04M | -$23.55M | -$65.68M | -$107.66M |
| EPS (diluted) | $0.51 | $0.53 | $-0.11 | $-0.32 | $-0.58 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $2.15B | $707.54M | $441.19M | $366.34M | $420.58M |
| Total liabilities | $1.61B | $230.82M | $97.16M | $54.60M | $85.97M |
| Shareholders’ equity | $540.93M | $476.72M | $344.03M | $311.74M | $334.62M |
| Cash and equivalents | $228.60M | $220.58M | $96.66M | $46.77M | $71.78M |
| Long-term debt | $1.12B | $9.46M | $8.67M | $3.65M | $4.12M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $300.00M | $251.08M | $73.48M | -$26.53M | -$34.41M |
| Capital expenditure | -$242.59M | -$52.75M | -$26.49M | -$7.25M | -$5.01M |
| Free cash flow | $57.41M | $198.33M | $46.99M | -$33.78M | -$39.42M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HIMS | $26.94 | -2.8% | 4.90M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Hims & Hers Health, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW